A study in Nature shows that uptake of nicotinamide adenine dinucleotide NAD by tumour cells takes one of two pathways depending on tissue type. Both pathways must be blocked for the tumour to shrink. httpsgo.nature.com2IG1sXhÂpic.twitter.comSY7

A study in Nature shows that uptake of nicotinamide adenine dinucleotide (NAD) by tumour cells takes one of two pathways, depending on tissue type. Both pathways must be blocked for the tumour to shrink. https://go.nature.com/2IG1sXh pic.twitter.com/SY7

10:51 EDT 26 Apr 2019 | Nature Publishing

A study in Nature shows that uptake of nicotinamide adenine dinucleotide (NAD) by tumour cells takes one of two pathways, depending on tissue type. Both pathways must be blocked for the tumour to shrink. https://go.nature.com/2IG1sXh pic.twitter.com/SY7Pent46I

More From BioPortfolio on "A study in Nature shows that uptake of nicotinamide adenine dinucleotide (NAD) by tumour cells takes one of two pathways, depending on tissue type. Both pathways must be blocked for the tumour to shrink. https://go.nature.com/2IG1sXh pic.twitter.com/SY7"